Log in

ETR:FMEFresenius Medical Care AG & Co. KGaA Price Target & Analyst Ratings

+0.02 (+0.03 %)
(As of 08/7/2020 04:00 PM ET)
Today's Range
Now: €72.72
50-Day Range
MA: €76.21
52-Week Range
Now: €72.72
Volume592,214 shs
Average Volume704,197 shs
Market Capitalization$22.15 billion
P/E Ratio16.58
Dividend Yield1.53%

Analyst Ratings

Fresenius Medical Care AG & Co. KGaA (ETR:FME) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
16 Wall Street analysts have issued ratings and price targets for Fresenius Medical Care AG & Co. KGaA in the last 12 months. Their average twelve-month price target is €82.95The high price target for FME is €100.00 and the low price target for FME is €68.00. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.632.632.562.60
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: €82.95€81.84€80.72€79.11

Fresenius Medical Care AG & Co. KGaA (ETR:FME) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Fresenius Medical Care AG & Co. KGaA (ETR:FME) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
8/7/2020Sanford C. BernsteinSet Price TargetNeutral€69.50
8/6/2020Nord/LBSet Price TargetBuy€82.00
8/5/2020Jefferies Financial GroupSet Price TargetNeutral€68.00
7/31/2020Independent ResearchSet Price TargetBuy€83.00
7/31/2020Credit Suisse GroupSet Price TargetNeutral€81.00
7/31/2020Deutsche BankSet Price TargetBuy€100.00
7/30/2020Warburg ResearchSet Price TargetNeutral€84.00
7/30/2020JPMorgan Chase & Co.Set Price TargetBuy€94.80
7/30/2020Goldman Sachs GroupSet Price TargetBuy€84.00
7/30/2020BarclaysSet Price TargetBuy€88.00
7/27/2020Berenberg BankSet Price TargetBuy€94.85
6/24/2020UBS GroupSet Price TargetBuy€95.00
5/20/2020Morgan StanleySet Price TargetNeutral€70.00
2/20/2020Kepler Capital MarketsSet Price TargetNeutral€70.00
11/18/2019HSBCSet Price TargetBuy€78.00
11/1/2019Bank of AmericaSet Price TargetBuy€85.00
12/7/2018CfraSet Price TargetNeutral€68.00
12/7/2018CommerzbankSet Price TargetNeutral€79.00
11/13/2018Societe GeneraleSet Price TargetNeutral€79.00
8/1/2018Oddo BhfSet Price TargetBuy€96.00
2/12/2018CitigroupSet Price TargetBuy€92.00
1/31/2018DZ BankSet Price TargetBuy€107.00
11/6/2017S&P GlobalSet Price TargetBuy€95.00
(Data available from 8/8/2018 forward)
This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.